Superworth

Medtronic EV/EBIT MDT

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2015.

Today, Oct 23, 2026
20.7×
10-year median
21.9×
Against its 10-year history
30th
percentile: 0 is its lowest day, 100 its highest
10-year range
17.8× to 52.1×
Peer median
23.4×

Medtronic's EV/EBIT is 20.7× as of Oct 23, 2026.

That is below its ten-year median of 21.9×, lower than on 70% of days in the last ten years.

Over that time it ranged from 17.8× in May 2026 to 52.1× in Apr 2021.

The median for 7 medical device stocks of a similar size is 23.4×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far20.7×17.8×23.2×
202522.0×19.8×23.7×
202420.6×20.2×23.8×
202321.3×18.4×23.3×
202218.7×18.3×25.5×
202124.4×23.8×52.1×
202042.8×18.1×42.8×
201925.6×19.8×25.7×
201821.0×18.3×22.7×
201720.0×20.0×25.1×
201620.7×20.7×29.0×
201527.0×26.8×27.2×

Against its peers

Companies in Medical - Devices nearest Medtronic's size, closest first, today.

CompanyEV/EBIT
MDTMedtronic20.7×
SYKStryker23.4×
ABTAbbott Laboratories28.2×
BSXBoston Scientific18.2×
EWEdwards Lifesciences23.5×
GEHCGE HealthCare Technologies14.7×
DXCMDexCom25.3×
ZBHZimmer Biomet21.5×
Peer median23.4×

Where Medtronic ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Medtronic

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.